Acro Biomedical Co., Ltd.
ACBM
$0.0007
-$0.1043-99.33%
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 360.00K | 360.00K | 658.50K | 896.50K | 896.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 360.00K | 360.00K | 658.50K | 896.50K | 896.50K |
| Cost of Revenue | 296.00K | 296.00K | 518.00K | 670.00K | 670.00K |
| Gross Profit | 64.00K | 64.00K | 140.50K | 226.50K | 226.50K |
| SG&A Expenses | 5.77M | 5.93M | 5.93M | 5.93M | 5.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.50M | 16.30M | 16.53M | 16.68M | 15.66M |
| Operating Income | -15.14M | -15.94M | -15.87M | -15.79M | -14.77M |
| Income Before Tax | -15.15M | -15.95M | -15.87M | -15.79M | -14.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.15 | -15.95 | -15.87 | -15.79 | -14.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.15M | -15.95M | -15.87M | -15.79M | -14.77M |
| EBIT | -15.14M | -15.94M | -15.87M | -15.79M | -14.77M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.25 | -0.27 | -0.26 | -0.26 | -0.25 |
| Normalized Basic EPS | -0.16 | -0.17 | -0.17 | -0.16 | -0.16 |
| EPS Diluted | -0.25 | -0.27 | -0.26 | -0.26 | -0.25 |
| Normalized Diluted EPS | -0.16 | -0.17 | -0.17 | -0.16 | -0.15 |
| Average Basic Shares Outstanding | 240.17M | 240.17M | 240.17M | 240.24M | 237.06M |
| Average Diluted Shares Outstanding | 244.04M | 240.17M | 240.17M | 240.24M | 240.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
